Revealing DNA polymerase molecular strategies in end-joining double strand break repair

Active Project Grant Awarded Last action

Award ID
R35GM165917
Recipient
Awarding agency
Obligated
$420,750

Award facts

Assistance listing
93.859 Biomedical Research and Research Training
Completion date 5% complete
Place of performance
Little Rock, AR 72205, USA

Award details come from USAspending.gov.

About this award

The National Institute of General Medical Sciences awarded the University of Arkansas for Medical Sciences $420,750 on August 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support research revealing DNA polymerase molecular strategies in end-joining double strand break repair.

The project integrates structural biology, mechanistic biochemistry, biophysics, computational methods, and molecular biology to uncover how DNA polymerases and nucleases process and repair double strand breaks through nonhomologous end joining. The research addresses how oxidative stress produces chemically modified breaks that alter enzymatic processing and repair pathway selection, and how erroneous repair pathways contribute to mutagenesis and chromosomal changes associated with cancer. The work will determine how polymerase and nuclease mechanisms modulate repair efficiency and fidelity within repair complexes and reveal effects of modified DNA ends on repair outcomes.

Performance occurs in Little Rock, Arkansas, with work scheduled through March 31, 2031. The award is structured as a project grant, the assistance type under which NIGMS prioritizes funding for investigator-initiated biomedical research of high scientific and technical merit.

Description

Abstract
DNA double strand breaks (dsbs) are highly cytotoxic and threaten the physical integrity of the genome. Repair of the majority of dsbs through nonhomologous end joining (nhej) is thus essential to cellular survival and function. Erroneous end joining can lead to mutagenesis and physical chromosomal changes that promote adverse human health outcomes and disease. Oxidative stress, generated by exposure to damaging agents in the cellular environment, is a prevalent source of cellular dsbs and produces chemically diverse structurally modified breaks and ends. These modified breaks modulate enzymatic end processing steps in DSB repair in a poorly understood manner, altering the processing and channeling of repair intermediates, and thus the molecular repair strategies and pathways employed to repair specific breaks. When nhej is challenged or blocked, highly erroneous repair pathways, such as microhomology mediated end joining, that often lead to mutagenesis and physical chromosomal changes prevalent in cancers, are recruited to complete repair. DSB repair polymerases and nucleases are crucial in break processing of especially damaged and modified ends and breaks. Despite progress in uncovering key features of accurate and erroneous repair, the molecular strategies of polymerases and nucleases in DSB repair remain poorly understood. This proposed mira effort will reveal detailed polymerase and nuclease atomic and molecular end processing mechanisms through a comprehensive approach that integrates cutting-edge structural biology, mechanistic biochemistry, biophysics, computational, and molecular biology. We have three related overarching goals: to uncover the mechanisms of DSB repair polymerases and nucleases in end joining, to determine how these mechanisms modulate the efficiency and fidelity of repair within the repair complex, and to reveal the effects of oxidative modifications of break substrates on repair strategies. The proposed projects will 1) elucidate the molecular fidelity strategies of DSB repair polymerases and nucleases and the impact of oxidative damage at authentic dsbs using time-resolved crystallography, mechanistic biochemistry, molecular and computational biology, 2) reveal the protein complex and the effects of the repair architecture on polymerase and nuclease functions using molecular biology, mechanistic biochemistry and cryo-EM, 3) uncover steps along repair that can possibly be modulated in a therapeutic setting. I am in a unique position to advance these efforts due to my strong track record in DNA repair, scientific experience and expertise, network of collaborators, outstanding institutional resources, and my multidisciplinary approach. Successful completion of these aims will resolve longstanding questions about fundamental molecular DSB repair strategies, especially upon oxidative modification. This work will thus provide transformative insights into DSB repair, and the effects of environmental stress on repair strategies, that will inform approaches to modulate repair in mechanism, biology, and disease.

Quick answers

Who received award R35GM165917?

R35GM165917 was awarded to University Of Arkansas For Medical Sciences by National Institute of General Medical Sciences (National Institutes of Health) on August 1, 2026.

How much is award R35GM165917 worth?

$420,750 has been obligated on R35GM165917.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award